WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

FDA approves Priftin generic for two types of tuberculosis

The FDA announced approval of generic Priftin tablets to treat two types of tuberculosis caused by Mycobacterium tuberculosis, marking the first generic of this drug, according to an agency notice.The FDA outlined that the generic of Priftin (rifapentine) is for patients aged 12 years and older with active pulmonary TB and for patients aged 2 years and older with latent tuberculosis infection at

Raccontata dahealio.commedpagetoday.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
healio.comStai leggendo14 g fa

FDA approves Priftin generic for two types of tuberculosis

The FDA announced approval of generic Priftin tablets to treat two types of tuberculosis caused by Mycobacterium tuberculosis, marking the first generic of this drug, according to an agency notice.The FDA outlined that…

originale
medpagetoday.com14 g fa

FDA Greenlights Generic Rifapentine for Tuberculosis

Generic approved as part of combination regimens for active and latent pulmonary TB

Leggi questa versione → originale

Timeline cronologica

  1. martedì 23 giugno 2026·healio.com

    FDA approves Priftin generic for two types of tuberculosis

    The FDA announced approval of generic Priftin tablets to treat two types of tuberculosis caused by Mycobacterium tuberculosis, marking the first generic of this drug, according to…

  2. martedì 23 giugno 2026·medpagetoday.com

    FDA Greenlights Generic Rifapentine for Tuberculosis

    Generic approved as part of combination regimens for active and latent pulmonary TB